ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PMN ProMIS Neurosciences Inc

交易中 11-26 11:35:02 EST

0.9650

+0.0450

+4.89%

最高0.9700	最低0.9601	成交量7,182
今开0.9700	昨收0.9200	日振幅1.08%
总市值3,155万	流通市值1,809万	总股本3,269万
成交额6,949	换手率0.04%	流通股本1,874万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PMN","market":"US","secType":"STK","nameCN":"ProMIS Neurosciences Inc","latestPrice":0.965,"timestamp":1732638801679,"preClose":0.92,"halted":0,"volume":7182,"delay":0,"floatShares":18743200,"shares":32689200,"eps":-0.025461,"marketStatus":"交易中","marketStatusCode":2,"change":0.045,"latestTime":"11-26 11:35:02 EST","open":0.97,"high":0.97,"low":0.9601,"amount":6949.093485599999,"amplitude":0.010761,"askPrice":1.09,"askSize":3001,"bidPrice":0.89,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.025461,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"adjPreClose":0.92,"preHourTrading":{"tag":"盘前","latestPrice":0.92,"preClose":0.92,"latestTime":"09:11 EST","volume":73,"amount":67.16,"timestamp":1732630291129},"postHourTrading":{"tag":"盘后","latestPrice":0.9338,"preClose":0.92,"latestTime":"19:40 EST","volume":564,"amount":524.3284,"timestamp":1732581608463},"volumeRatio":0.596526},"requestUrl":"/m/hq/s/PMN/tweets","defaultTab":"tweets","newsList":[{"id":"2486007556","title":"Promis Neurosciences Inc.盘中异动 早盘急速上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486007556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486007556?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:23","pubTimestamp":1732634604,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时23分，Promis Neurosciences Inc.股票出现异动，股价急速上涨5.43%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232325971a8aa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232325971a8aa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXD","BK4139","ARFXF"],"gpt_icon":0},{"id":"2486032193","title":"Promis Neurosciences Inc.盘中异动 股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486032193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486032193?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:40","pubTimestamp":1732552838,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时40分，Promis Neurosciences Inc.股票出现异动，股价快速跳水5.78%。截至发稿，该股报0.970美元/股，成交量5179股，换手率0.02%，振幅2.91%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为1.75%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126004038a254c900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126004038a254c900&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2485621131","title":"Promis Neurosciences Inc.盘中异动 大幅上涨5.76%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485621131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485621131?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:47","pubTimestamp":1732308451,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时47分，Promis Neurosciences Inc.股票出现异动，股价快速上涨5.76%。截至发稿，该股报1.010美元/股，成交量4.2349万股，换手率0.13%，振幅5.24%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123044731a24eb51a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123044731a24eb51a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"gpt_icon":0},{"id":"2485129877","title":"Promis Neurosciences Inc.2024财年第三财季实现净利润9.28百万美元，同比增加493.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485129877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485129877?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291383,"startTime":"0","endTime":"0","summary":"11月23日，Promis Neurosciences Inc.公布财报，公告显示公司2024财年第三财季净利润为9.28百万美元，同比增加493.22%；其中营业收入为0.00美元，每股基本收益为0.31美元。从资产负债表来看，Promis Neurosciences Inc.总负债17.24百万美元，其中短期债务0.00美元，资产负债比为1.43，流动比率为9.29。机构评级：截至2024年11月23日，当前有2家机构对Promis Neurosciences Inc.目标价做出预测，其中目标均价为8.75美元，其中最低目标价为8.00美元，最高目标价为9.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000331a24e49a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000331a24e49a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","PMN"],"gpt_icon":0},{"id":"2485788621","title":"Promis Neurosciences Inc.盘中异动 临近收盘股价大跌5.05%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485788621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485788621?lang=zh_cn&edition=full","pubTime":"2024-11-21 04:40","pubTimestamp":1732135231,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日04时40分，Promis Neurosciences Inc.股票出现波动，股价快速下跌5.05%。截至发稿，该股报0.940美元/股，成交量2.6426万股，换手率0.08%，振幅5.60%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121044031971a7c19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121044031971a7c19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","ARFXD","PMN"],"gpt_icon":0},{"id":"2484988502","title":"Promis Neurosciences Inc.盘中异动 下午盘快速拉升6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484988502?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:26","pubTimestamp":1731957972,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时26分，Promis Neurosciences Inc.股票出现波动，股价急速拉升6.12%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032612abcd27ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032612abcd27ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","ARFXD","PMN"],"gpt_icon":0},{"id":"2482708464","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.05%报1.040美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482708464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482708464?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:44","pubTimestamp":1731422641,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时44分，Promis Neurosciences Inc.股票出现波动，股价快速上涨5.05%。截至发稿，该股报1.040美元/股，成交量3405股，换手率0.01%，振幅7.07%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222440195be19e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222440195be19e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2482732610","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482732610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482732610?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:15","pubTimestamp":1731341745,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时15分，Promis Neurosciences Inc.股票出现波动，股价快速下跌6.55%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001545a22d1b8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001545a22d1b8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","PMN","BK4139"],"gpt_icon":0},{"id":"2481110101","title":"Promis Neurosciences Inc.盘中异动 急速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110101","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110101?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:30","pubTimestamp":1731076255,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时30分，Promis Neurosciences Inc.股票出现异动，股价大幅上涨5.88%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822305598e41766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822305598e41766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMN","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2481037187","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481037187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481037187?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:36","pubTimestamp":1730993783,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时36分，Promis Neurosciences Inc.股票出现异动，股价快速上涨5.45%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107233623abaa9595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107233623abaa9595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2481605014","title":"重启！一亏损企业申请IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481605014","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481605014?lang=zh_cn&edition=full","pubTime":"2024-11-06 20:42","pubTimestamp":1730896920,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　近期，一亏损企业申请IPO并获受理。　　北京天广实生物技术股份有限公司申报北交所IPO于2024年11月4日获得受理，系近期来少有的亏损企业申请IPO。公司本次IPO拟募资3.49亿余元。公司目前注册资本7506.9641万元，公司控股股东为华泰君实，实际控制人为李锋，中国国籍，拥有美国永久居留权。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2024-11-06/doc-incvcvry1647817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4017","SLE","PMN","CDE","BK4585","BK4139","FL","BK4094","CDC","BK4588","BK4077"],"gpt_icon":0},{"id":"2481342095","title":"Promis Neurosciences Inc.盘中异动 股价大跌6.09%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481342095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481342095?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:42","pubTimestamp":1730742174,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时42分，Promis Neurosciences Inc.股票出现异动，股价快速下跌6.09%。截至发稿，该股报1.08美元/股，成交量1.5672万股，换手率0.05%，振幅5.88%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014254971a439d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014254971a439d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","PMN","ARFXF"],"gpt_icon":0},{"id":"2480889169","title":"Promis Neurosciences Inc.盘中异动 股价大涨5.51%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889169?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:30","pubTimestamp":1730467859,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时30分，Promis Neurosciences Inc.股票出现波动，股价快速拉升5.51%。截至发稿，该股报1.34美元/股，成交量3851股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121305998e3ffcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121305998e3ffcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","BK4139","ARFXD"],"gpt_icon":0},{"id":"2479603838","title":"Promis Neurosciences Inc.盘中异动 急速上涨9.17%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479603838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479603838?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:46","pubTimestamp":1730382403,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时46分，Promis Neurosciences Inc.股票出现异动，股价快速上涨9.17%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为2.16%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121464398e3fb7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121464398e3fb7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2479078301","title":"Promis Neurosciences Inc.盘中异动 快速拉升6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479078301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479078301?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:34","pubTimestamp":1730295262,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时34分，Promis Neurosciences Inc.股票出现异动，股价快速上涨6.31%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021342298e3f672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021342298e3f672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","BK4139","ARFXD"],"gpt_icon":0},{"id":"2478480434","title":"Promis Neurosciences Inc.盘中异动 大幅下跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478480434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478480434?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:36","pubTimestamp":1730126207,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时36分，Promis Neurosciences Inc.股票出现异动，股价快速跳水5.47%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223647ab7be91a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223647ab7be91a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","BK4139","ARFXF"],"gpt_icon":0},{"id":"2478467650","title":"Promis Neurosciences Inc.盘中异动 下午盘快速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478467650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478467650?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:02","pubTimestamp":1729789373,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时02分，Promis Neurosciences Inc.股票出现波动，股价快速拉升5.36%。截至发稿，该股报1.000美元/股，成交量3.2597万股，换手率0.11%，振幅7.38%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025010253ab710f4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025010253ab710f4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2477286253","title":"Promis Neurosciences Inc.盘中异动 股价大跌7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477286253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477286253?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:53","pubTimestamp":1729522439,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时53分，Promis Neurosciences Inc.股票出现波动，股价急速下挫7.08%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122535998e3d8fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122535998e3d8fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","ARFXF","PMN"],"gpt_icon":0},{"id":"2475736360","title":"Promis Neurosciences Inc.盘中异动 大幅下挫5.87%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475736360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475736360?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:08","pubTimestamp":1728914905,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时08分，Promis Neurosciences Inc.股票出现异动，股价快速下挫5.87%。截至发稿，该股报0.960美元/股，成交量4474股，换手率0.01%，振幅5.88%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220825ab69fde9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220825ab69fde9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0728928796.USD","LU0053671581.USD","LU0757428866.USD","BK4139","MSA","BK4143","LU1923622291.USD","PMN","LU2125909759.SGD","LU1815336091.USD","LU2125909916.SGD"],"gpt_icon":0},{"id":"2474979300","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨5.88%报1.069美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474979300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474979300?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:44","pubTimestamp":1728654277,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时44分，Promis Neurosciences Inc.股票出现异动，股价急速拉升5.88%。截至发稿，该股报1.069美元/股，成交量7728股，换手率0.03%，振幅7.96%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121443798e3be14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121443798e3be14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","PMN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.promisneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.098},{"period":"1month","weight":-0.0997},{"period":"3month","weight":-0.2815},{"period":"6month","weight":-0.4714},{"period":"1year","weight":-0.3185},{"period":"ytd","weight":-0.2}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立，位于安大略省多伦多市央街1920号。该公司正在应用其专利技术平台，在神经退行性疾病和其他错误折叠的蛋白质疾病（包括阿尔茨海默病多系统萎缩和肌萎缩性侧索硬化症）中构建抗体疗法、治疗性疫苗和其他基于抗体的疗法组合。该公司还计划研究其他突触核蛋白病，包括帕金森病和路易体痴呆、额颞叶变性、进行性核上性麻痹、皮质基底节变性和精神分裂症。这些疾病有一个共同的生物学原因——错误折叠的蛋白质，否则会发挥正常功能，变得有毒并杀死神经元，从而导致疾病。ProMIS的技术平台是通过计算能力、计算机发现和人工智能实现药物发现进步的一个例子。","exchange":"NASDAQ","name":"ProMIS Neurosciences Inc","nameEN":"ProMIS Neurosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProMIS Neurosciences Inc,PMN,ProMIS Neurosciences Inc股票,ProMIS Neurosciences Inc股票老虎,ProMIS Neurosciences Inc股票老虎国际,ProMIS Neurosciences Inc行情,ProMIS Neurosciences Inc股票行情,ProMIS Neurosciences Inc股价,ProMIS Neurosciences Inc股市,ProMIS Neurosciences Inc股票价格,ProMIS Neurosciences Inc股票交易,ProMIS Neurosciences Inc股票购买,ProMIS Neurosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}